1. Adams RD, Foley JM. The neurological disorder associated with liver disease. In: Metabolic and Toxic Diseases of the Nervous System. (H.H. Merritt, and C.C. Hare, eds.)Vol. 32. Williams and Wilkins, Baltimore, USA, pp. 198-237, 1953
2. Ahboucha S, Butterworth RF. The neurosteroid system: Implication in the pathophysiology of hepatic encephalopathy. Neurochem. Int., 52, 575-587, 2008
3. Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF. Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. Ann. Neurol., 58, 169-170, 2005
4. Ahboucha S, Coyne L, Hirakawa R, Butterworth RF, Halliwell RF. An interaction between benzodiazepines and neuroactive steroids at GABAA receptors in cultured hippocampal neurons. Neurochem. Int., 48, 703-707, 2006
5. Bates TE, Williams SR, Kauppinen RA, Godian DG. Observation of cerebral metabolites in an animal model of ALF in vivo: 1H and 31P nuclear magnetic resonance study. J. Neurochem., 53, 102-110, 1989